Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4609
Gene Symbol: MYC
MYC 		0.110 Biomarker group HPO
Entrez Id: 7486
Gene Symbol: WRN
WRN 		0.100 Biomarker group HPO
Entrez Id: 4000
Gene Symbol: LMNA
LMNA 		0.100 Biomarker group HPO
Entrez Id: 4893
Gene Symbol: NRAS
NRAS 		0.210 GeneticVariation group BEFREE Oral tumor specimens (n = 50) from eastern Indian population were studied for the presence of mutations in the H-, K- and N-ras genes using selective oligodeoxynucleotide hybridization and restriction fragment length polymorphism analysis of polymerase chain reaction-amplified products. 10889924 2000
Entrez Id: 7431
Gene Symbol: VIM
VIM 		0.010 AlteredExpression group BEFREE Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells. 26646105 2016
Entrez Id: 407055
Gene Symbol: MIR99A
MIR99A 		0.010 AlteredExpression group BEFREE MiR-99a-5p was under-expressed in human oral tumor, while NOX4 was over-expressed. 28592118 2019
Entrez Id: 8519
Gene Symbol: IFITM1
IFITM1 		0.010 AlteredExpression group BEFREE IFITM1 expression was quantified by quantitative RT-PCR and immunohistochemistry in 19 paired oral neoplasm cases. 29770536 2018
Entrez Id: 6387
Gene Symbol: CXCL12
CXCL12 		0.010 GeneticVariation group LHGDN A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer. 18383856 2008
Entrez Id: 4322
Gene Symbol: MMP13
MMP13 		0.020 GeneticVariation group LHGDN A metalloproteinase-13 polymorphism affecting its gene expression is associated with advanced stages of oral cancer. 18225566 2008
Entrez Id: 4318
Gene Symbol: MMP9
MMP9 		0.030 GeneticVariation group LHGDN A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma. 17498910 2008
Entrez Id: 2074
Gene Symbol: ERCC6
ERCC6 		0.010 GeneticVariation group LHGDN A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. 17933579 2008
Entrez Id: 1634
Gene Symbol: DCN
DCN 		0.010 AlteredExpression group LHGDN Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. 14633702 2003
Entrez Id: 595
Gene Symbol: CCND1
CCND1 		0.020 AlteredExpression group LHGDN Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. 15791567 2005
Entrez Id: 1956
Gene Symbol: EGFR
EGFR 		0.020 AlteredExpression group LHGDN Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. 15791567 2005
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1 		0.010 AlteredExpression group LHGDN Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. 15791567 2005
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A 		0.340 AlteredExpression group LHGDN Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer. 14719099 2004
Entrez Id: 2272
Gene Symbol: FHIT
FHIT 		0.010 AlteredExpression group LHGDN Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer. 14719099 2004
Entrez Id: 3845
Gene Symbol: KRAS
KRAS 		0.310 GeneticVariation group BEFREE Although it is unclear why different codon 12 alleles occur in different disease contexts and the complex interactions between tumor genotype and phenotype need clarification, on the basis of our results the presence of KRAS p.G12V/R favors the adenomatoid odontogenic tumor diagnosis in challenging oral neoplasm cases. 30643167 2019
Entrez Id: 26959
Gene Symbol: HBP1
HBP1 		0.010 Biomarker group BEFREE Analysis of oral tumor specimens revealed that the low HBP1 (<0.3-fold)/high MMP-13 (>3-fold) status was associated with metastatic potential. 30191992 2019
Entrez Id: 4322
Gene Symbol: MMP13
MMP13 		0.020 Biomarker group BEFREE Analysis of oral tumor specimens revealed that the low HBP1 (<0.3-fold)/high MMP-13 (>3-fold) status was associated with metastatic potential. 30191992 2019
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.550 GeneticVariation group LHGDN Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. 17306604 2007
Entrez Id: 4314
Gene Symbol: MMP3
MMP3 		0.010 GeneticVariation group LHGDN Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer. 18225577 2008
Entrez Id: 7157
Gene Symbol: TP53
TP53 		0.550 GeneticVariation group LHGDN Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. 17595776 2007
Entrez Id: 1026
Gene Symbol: CDKN1A
CDKN1A 		0.010 GeneticVariation group LHGDN Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. 17595776 2007
Entrez Id: 3673
Gene Symbol: ITGA2
ITGA2 		0.010 GeneticVariation group LHGDN Association of platelet glycoprotein Ia polymorphism with minor increase of risk for oral cancer. 16513317 2006